Literature DB >> 16113295

Biochemical characterization and functional studies of Acanthamoeba mannose-binding protein.

Marco Garate1, Ibis Cubillos, Jeffrey Marchant, Noorjahan Panjwani.   

Abstract

Acanthamoebae produce a painful, sight-threatening corneal infection. The adhesion of parasites to the host cells is a critical first step in the pathogenesis of infection. Subsequent to adhesion, the parasites produce a potent cytopathic effect (CPE) leading to target cell death. Recent studies showing that acanthamoebae express a mannose-binding protein (MBP) and that free alpha-mannose (alpha-Man) specifically inhibits the adhesion of parasites to host cells suggest that the MBP plays a key role in the pathogenesis of Acanthamoeba infection by mediating host-parasite interactions. However, direct evidence showing that Acanthamoeba MBP is a virulence protein has been lacking. In this study, we demonstrate that the polyclonal immunoglobulin Y (IgY) antibodies prepared against affinity-purified Acanthamoeba MBP markedly inhibit the adhesion of parasites to host cells. The antibody also inhibited the Acanthamoeba-induced CPE on host cells. In contrast, preimmune IgY did not influence either the adhesion of the parasites to host cells or the amoeba-induced CPE. Using a variety of approaches, including affinity chromatography on an alpha-Man gel, electrophoresis under native and denaturing conditions, biotinylation of cell surface proteins, and immunostaining, it was conclusively established that Acanthamoeba MBP is located on the surface membranes of the parasites. Neutral-sugar analysis and lectin binding experiments using succinylated concanavalin A, a plant lectin with high affinity for mannose, revealed that Acanthamoeba MBP is itself a mannose-containing glycoprotein. N-Glycanase treatment to remove N-linked oligosaccharides shifted the subunit molecular mass of MBP from 130 kDa to 110 kDa. Hexosamine analysis revealed that Acanthamoeba MBP lacks detectable levels of GalNAc, suggesting the absence of O-linked oligosaccharides. In summary, we have characterized Acanthamoeba MBP and have shown that it is a major virulence protein responsible for host-parasite interactions and the parasite-induced target cell destruction.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16113295      PMCID: PMC1231072          DOI: 10.1128/IAI.73.9.5775-5781.2005

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  25 in total

Review 1.  The increasing importance of Acanthamoeba infections.

Authors:  F Marciano-Cabral; R Puffenbarger; G A Cabral
Journal:  J Eukaryot Microbiol       Date:  2000 Jan-Feb       Impact factor: 3.346

Review 2.  Recent advances in the treatment of Acanthamoeba keratitis.

Authors:  Raman Kumar; David Lloyd
Journal:  Clin Infect Dis       Date:  2002-07-16       Impact factor: 9.079

3.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

4.  Axenic cultivation of large populations of Acanthamoeba castellanii (JBM).

Authors:  T Jensen; W G Barnes; D Meyers
Journal:  J Parasitol       Date:  1970-10       Impact factor: 1.276

Review 5.  Role of N-oligosaccharide endoplasmic reticulum processing reactions in glycoprotein folding and degradation.

Authors:  A J Parodi
Journal:  Biochem J       Date:  2000-05-15       Impact factor: 3.857

6.  Acanthamoeba keratitis in England and Wales: incidence, outcome, and risk factors.

Authors:  C F Radford; D C Minassian; J K G Dart
Journal:  Br J Ophthalmol       Date:  2002-05       Impact factor: 4.638

7.  Cloning and characterization of a novel mannose-binding protein of Acanthamoeba.

Authors:  Marco Garate; Zhiyi Cao; Erik Bateman; Noorjahan Panjwani
Journal:  J Biol Chem       Date:  2004-04-26       Impact factor: 5.157

Review 8.  Acanthamoeba spp. as agents of disease in humans.

Authors:  Francine Marciano-Cabral; Guy Cabral
Journal:  Clin Microbiol Rev       Date:  2003-04       Impact factor: 26.132

9.  Characterization and pathogenic potential of a soil isolate and an ocular isolate of Acanthamoeba castellanii in relation to Acanthamoeba keratitis.

Authors:  F van Klink; H Alizadeh; G L Stewart; M S Pidherney; R E Silvany; Y He; J P McCulley; J Y Niederkorn
Journal:  Curr Eye Res       Date:  1992-12       Impact factor: 2.424

10.  Acanthamoeba keratitis: the role of domestic tap water contamination in the United Kingdom.

Authors:  Simon Kilvington; Trevor Gray; John Dart; Nigel Morlet; John R Beeching; David G Frazer; Melville Matheson
Journal:  Invest Ophthalmol Vis Sci       Date:  2004-01       Impact factor: 4.799

View more
  18 in total

1.  Oral immunization with Acanthamoeba castellanii mannose-binding protein ameliorates amoebic keratitis.

Authors:  M Garate; H Alizadeh; S Neelam; J Y Niederkorn; N Panjwani
Journal:  Infect Immun       Date:  2006-09-18       Impact factor: 3.441

2.  Photochemotherapeutic strategy against Acanthamoeba infections.

Authors:  Yousuf Aqeel; Ruqaiyyah Siddiqui; Ayaz Anwar; Muhammad Raza Shah; Shahrukh Khoja; Naveed Ahmed Khan
Journal:  Antimicrob Agents Chemother       Date:  2015-03-09       Impact factor: 5.191

Review 3.  Pathogenesis of acanthamoeba keratitis.

Authors:  Noorjahan Panjwani
Journal:  Ocul Surf       Date:  2010-04       Impact factor: 5.033

4.  Chromosome-scale assemblies of Acanthamoeba castellanii genomes provide insights into Legionella pneumophila infection-related chromatin reorganization.

Authors:  Cyril Matthey-Doret; Morgan J Colp; Pedro Escoll; Agnès Thierry; Pierrick Moreau; Bruce Curtis; Tobias Sahr; Matt Sarrasin; Michael W Gray; B Franz Lang; John M Archibald; Carmen Buchrieser; Romain Koszul
Journal:  Genome Res       Date:  2022-09-15       Impact factor: 9.438

5.  Binding of serum mannan binding lectin to a cell integrity-defective Cryptococcus neoformans ccr4Delta mutant.

Authors:  John C Panepinto; Kazimierz W Komperda; Moshe Hacham; Soowan Shin; Xiaoguang Liu; Peter R Williamson
Journal:  Infect Immun       Date:  2007-07-23       Impact factor: 3.441

6.  Exploring the unique N-glycome of the opportunistic human pathogen Acanthamoeba.

Authors:  Birgit Schiller; Georgia Makrypidi; Ebrahim Razzazi-Fazeli; Katharina Paschinger; Julia Walochnik; Iain B H Wilson
Journal:  J Biol Chem       Date:  2012-11-08       Impact factor: 5.157

7.  Molecular Identification and Sequencing of Mannose Binding Protein (MBP) Gene of Acanthamoeba palestinensis.

Authors:  M Niyyati; S Rezaie; Z Babaei; M Rezaeian
Journal:  Iran J Parasitol       Date:  2010-03       Impact factor: 1.012

Review 8.  An update on Acanthamoeba keratitis: diagnosis, pathogenesis and treatment.

Authors:  Jacob Lorenzo-Morales; Naveed A Khan; Julia Walochnik
Journal:  Parasite       Date:  2015-02-18       Impact factor: 3.000

Review 9.  Current Status of Acanthamoeba in Iran: A Narrative Review Article.

Authors:  Maryam Niyyati; Mostafa Rezaeian
Journal:  Iran J Parasitol       Date:  2015 Apr-Jun       Impact factor: 1.012

10.  Genome of Acanthamoeba castellanii highlights extensive lateral gene transfer and early evolution of tyrosine kinase signaling.

Authors:  Michael Clarke; Amanda J Lohan; Bernard Liu; Ilias Lagkouvardos; Scott Roy; Nikhat Zafar; Claire Bertelli; Christina Schilde; Arash Kianianmomeni; Thomas R Bürglin; Christian Frech; Bernard Turcotte; Klaus O Kopec; John M Synnott; Caleb Choo; Ivan Paponov; Aliza Finkler; Chris Soon Heng Tan; Andrew P Hutchins; Thomas Weinmeier; Thomas Rattei; Jeffery S C Chu; Gregory Gimenez; Manuel Irimia; Daniel J Rigden; David A Fitzpatrick; Jacob Lorenzo-Morales; Alex Bateman; Cheng-Hsun Chiu; Petrus Tang; Peter Hegemann; Hillel Fromm; Didier Raoult; Gilbert Greub; Diego Miranda-Saavedra; Nansheng Chen; Piers Nash; Michael L Ginger; Matthias Horn; Pauline Schaap; Lis Caler; Brendan J Loftus
Journal:  Genome Biol       Date:  2013-02-01       Impact factor: 13.583

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.